Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

News
02/01/2024

Tom Valentino

Tom Valentino
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive...
02/01/2024
Addiction Professional
Study Reveals Significant Cognitive Impairment in Patients With MDD
News
01/31/2024
Meagan Thistle
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major depressive disorder may have significant moderate cognitive deficits in executive function, memory, and attention, when compared to healthy subjects. Researchers published their findings in Psychotherapy and...
Individuals with major...
01/31/2024
Psych Congress Network
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
News
01/29/2024
Evi Arthur
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or...
01/29/2024
Psych Congress Network
a doctor holds a generic orange pill bottle
News
01/29/2024
Meagan Thistle
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has...
01/29/2024
Neurology
News
01/26/2024

Tom Valentino

Tom Valentino
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10...
01/26/2024
Addiction Professional
FDA
News
01/26/2024
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation of GLP-1 RAs found no evidence that the medications cause suicidal drugs or actions but cautions that a small risk cannot yet be ruled out.
The FDA's preliminary evaluation...
01/26/2024
Psych Congress Network
Dr Leslie Citrome
Q&As
01/25/2024

Featuring Leslie Citrome, MD, MPH

Featuring Leslie Citrome, MD, MPH ...
In this Q&A, Leslie Citrome, MD, MPH, discusses why work productivity and quality of life are important considerations when treating patients with bipolar disorder, how to prevent them, and why using a wide dosing range can be beneficial. 
In this Q&A, Leslie Citrome, MD, MPH, discusses why work productivity and quality of life are important considerations when treating patients with bipolar disorder, how to prevent them, and why using a wide dosing range can be beneficial. 
In this Q&A, Leslie Citrome, MD,...
01/25/2024
Psych Congress Network
Traumatic Events May Affect Psychiatric Disorder Development, Moreso Than Familial Factors
News
01/23/2024
Evi Arthur
Assault, bereavement, and injury were significantly associated with an increased risk of subsequent psychiatric disorders, independent of familial background, in a nationwide cohort study recently published in JAMA Psychiatry. 
Assault, bereavement, and injury were significantly associated with an increased risk of subsequent psychiatric disorders, independent of familial background, in a nationwide cohort study recently published in JAMA Psychiatry. 
Assault, bereavement, and injury...
01/23/2024
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
01/23/2024
Jolynn Tumolo
Patients with early-onset psychosis had significantly lower volume of gray matter in their brains compared with healthy control subjects, according to study findings published in Molecular Psychiatry.
Patients with early-onset psychosis had significantly lower volume of gray matter in their brains compared with healthy control subjects, according to study findings published in Molecular Psychiatry.
Patients with early-onset...
01/23/2024
Psych Congress Network
Woman with dog
SPONSORED VIDEO
01/19/2024
Listen to Ashley, an adult with ADHD, share her personal ADHD journey including her current treatment with a nonstimulant medication.
Listen to Ashley, an adult with ADHD, share her personal ADHD journey including her current treatment with a nonstimulant medication.
Listen to Ashley, an adult with...
01/19/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement